[ACE gene polymorphism as a risk factor in the development of hypertensive organ damage].
Yamasaki
Eiji
E
Department of Geriatric Medicine, Ehime University School of Medicine.
Nakura
Jun
J
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001581:Benzothiadiazines; D004232:Diuretics; D005081:Exercise Therapy; D006801:Humans; D006973:Hypertension / Q000235:genetics* / Q000628:therapy; D007703:Peptidyl-Dipeptidase A / Q000235:genetics*; D010597:Pharmacogenetics; D011110:Polymorphism, Genetic; D012084:Renin-Angiotensin System / Q000235:genetics / Q000502:physiology; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D007703:Peptidyl-Dipeptidase A